Metsera, Inc. — Investor Relations & Filings
Metsera, Inc. is a clinical-stage biopharmaceutical company focused on developing next-generation medicines for obesity and related metabolic diseases. The company's portfolio includes both injectable and oral therapeutic candidates based on nutrient-stimulated hormone (NuSH) analog peptides. Leveraging a proprietary peptide engineering platform, Metsera aims to create potent, ultra-long-acting therapies with improved durability, bioavailability, and manufacturability. The company's approach is designed to deliver scalable treatments, including oral options with injectable-like performance, to enhance effectiveness, tolerability, and long-term patient adherence.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| SCHEDULE 13G/A Filing | 2026-02-17 | English | |
| 15-12G | 2025-11-24 | English | |
| Major Shareholding Notification 2025 | 2025-11-17 | English | |
| 4 | 2025-11-17 | English | |
| STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 2025-11-14 | English | |
| Major Shareholding Notification 2025 | 2025-11-14 | English |
Browse filings by year
3 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
1 filing
| |||||
| 32333724 | SCHEDULE 13G/A Filing | 2026-02-17 | English | ||
|
2025
14 filings
| |||||
| 13718408 | 15-12G | 2025-11-24 | English | ||
| 13718409 | Major Shareholding Notification 2025 | 2025-11-17 | English | ||
| 13718410 | 4 | 2025-11-17 | English | ||
| 13718411 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 2025-11-14 | English | ||
| 13718412 | Major Shareholding Notification 2025 | 2025-11-14 | English | ||
| 13718413 | Major Shareholding Notification 2025 | 2025-11-13 | English | ||
| 13718414 | 4 | 2025-11-13 | English | ||
| 13718415 | 4 | 2025-11-13 | English | ||
| 13718417 | 4 | 2025-11-13 | English | ||
| 13718416 | 4 | 2025-11-13 | English | ||
| 13718419 | 4 | 2025-11-13 | English | ||
| 13718418 | 4 | 2025-11-13 | English | ||
| 13718420 | 4 | 2025-11-13 | English | ||
| 13718421 | 4 | 2025-11-13 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
Develops and manufactures IVD reagents and vaccines for inf…
|
603392 | CN | Manufacturing |
|
Beleave Inc.
Vertically integrated cannabis company engaged in cultivati…
|
BLEVF | CA | Manufacturing |
|
BELITE BIO, INC
Clinical-stage biopharma developing therapies for retinal a…
|
BLTE | KY | Manufacturing |
|
Benitec Biopharma Inc.
A clinical-stage biotech developing genetic medicines to si…
|
BNTC | US | Manufacturing |
|
BeOne Medicines Ltd.
Global oncology company that discovers, develops, and deliv…
|
ONC | KY | Manufacturing |
|
BEONE MEDICINES LTD.
Biopharmaceutical firm developing targeted oncology therapi…
|
688235 | CN | Manufacturing |
|
BerGenBio
Clinical-stage biopharma that developed selective AXL kinas…
|
BGBIO | NO | Manufacturing |
|
Beryl Drugs Ltd.
Manufactures IV fluids and small volume parenterals for cli…
|
524606 | IN | Manufacturing |
|
BESHOM HOLDINGS BERHAD
An investment holding company with diversified operations i…
|
— | MY | Manufacturing |
|
Besunyen Holdings Company Limited
Leading supplier of functional health teas, weight manageme…
|
926 | HK | Manufacturing |
Metsera, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/30975/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=30975 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=30975 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=30975 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 30975}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Metsera, Inc. (id: 30975)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.